Interní Med. 2012; 14(10): 350-356
Chronic obstructive pulmonary disease (COPD) and asthma have several different but also similar characteristics in diagnosis and therapy.
There are different etiologic factors they play the main role (in COPD mostly inhaled harmful irritants, in asthma allergic triggers. The
most important parameter of differences between COPD and asthma are lung function results of bronchial obstruction and its reversibility.
Both diseases are generally under diagnosed and some mistakes are frequent. Correct diagnoses have important influence on
early and optimal therapy according the stage of COPD, and control and severity of asthma. Indacaterol (Onbrez Breezhaler) and roflumilast
(Daxas) were introduced in the year 2011 into the therapy of COPD in the Czech Republic. New modern effective and expensive
treatment of asthma with antibody against IgE (Omalizumab-Xolair) has special indication.
Published: November 1, 2012 Show citation